Press "Enter" to skip to content

Soaring insulin prices in the US are costing Medicare billions

Soaring insulin prices in the US are costing Medicare billions

2007_07_31T120000Z_1209784506_.jpg

Insulin prices have sparked outrage in recent months, with Congress holding hearings on the issue and launching bipartisan investigations into why the cost of the hormone used to treat diabetes – discovered nearly a century ago – has soared over the past two decades. The House Energy and Commerce oversight subcommittee held a hearing on insulin prices this week and will hold another next week. Executives from the three companies that dominate the global insulin market – Eli Lilly, Novo Nordisk and Sanofi – are expected to testify at the upcoming hearing. “We want to know why the cost of this life-saving drug has skyrocketed in recent years, and why they’re not offering more lower-cost alternatives to patients,” Rep. Diana DeGette (D-CO), who chairs the subcommittee, said this week.
Source: Soaring insulin prices in the US are costing Medicare billions

Disqus Comments

Specify a Disqus shortname at Social Comments options page in admin panel

Facebook Comments

Mission News Theme by Compete Themes.